| ★ | How Continuous Glucose Monitoring Will Evolve for #type2diabetes | | 59 | Estados Unidos | |
| 16 | The problem with glucose tracking. | The Unlazy Way @theunlazyway | 10.4K | Finlandia | 87 |
| 8 | The problem with continuous glucose monitors | Andrew Steele @drandrewsteele | 5.7K | Alemania | 88 |
| 12 | Sibionics Blood Glucose Sensor Review - The Medical Futurist | The Medical Futurist @medicalfuturist | 4.3K | Hungría | 88 |
| 6 | Let's put on a Continuous Glucose Monitor (CGM) # Stelo #conciergemedicine #blossomfamilymed #cgm | Blossom Family Medicine @blossomfamilymed | 4.3K | Estados Unidos | 88 |
| 14 | Diabetes Dialogue: Omnipod and AID Advancements at Insulet, With Trang Ly, PhD, MBBS | | 4.3K | Estados Unidos | 87 |
| 20 | T1D: She Lived With Type 1 Diabetes for 34 Years Before Learning This | | 657 | Estados Unidos | 87 |
| 17 | Diabetes Dialogue: A New Player in Tubeless Insulin Pumps The Pivot Patch | | 649 | Estados Unidos | 87 |
| 18 | Diabetes Dialogue: The ADA’s Statement on Diabetes Tech Integration, With Eugene Wright Jr., MD | | 584 | Estados Unidos | 87 |
| 2 | Diabetes Technology at a Turning Point: What’s New and What’s Next | | 581 | Estados Unidos | 89 |
| 7 | Why Glucose Alone Isn't Enough: The Future of Ketone Monitoring in Diabetes | | 475 | Estados Unidos | 88 |
| 3 | Is Continuous Ketone Monitoring Future of Diabetes Care? | | 270 | Estados Unidos | 89 |
| 1 | Continuous Glucose Monitoring in Type 2 Diabetes, With John Anderson, MD | | 196 | Estados Unidos | 95 |
| 10 | Diabetes Dialogue: CKM Systems, Triple Agonists, and a Sensor Scandal Ahead of ADA | | 179 | Estados Unidos | 88 |
| 11 | Diabetes Dialogue: Evolving Wearable Insulin Delivery Devices - AID, CGM, and More | | 139 | Estados Unidos | 88 |
| 5 | Diabetes Dialogue: Diabetes Technology and Treatment in the UK, With Ketan Dhatariya, MD, PhD, MS | | 94 | Estados Unidos | 89 |
| 4 | Unlock Your Health: Understanding Blood Sugar with Continuous Glucose Monitors (CGMs) | | 93 | — | 89 |
| 13 | Incretins, Monitors, and Insulin Titration at ADA 2026 | | 76 | Estados Unidos | 87 |
| 19 | GLP-1 Discontinuation in Type 2 Diabetes: What Happens When Patients Stop? | | 64 | Estados Unidos | 87 |
| 15 | Screening for Type 1 Diabetes in Adults: What Needs to Change | | 42 | Estados Unidos | 87 |
| 9 | Continuous Ketone Monitoring May Guide SGLT2i Use in T1D | | 33 | Estados Unidos | 88 |